Table 1.
Variant KRAS allele | Non-variant (wt) KRAS allele | p-Value | |
---|---|---|---|
Age | 34.1 | 31.3 | 0.35 |
Stage IV disease | 57% | 56% | 1 |
Years from diagnosis | 9 | 6 | 0.31 |
Infertility | 42% | 18% | 0.003 |
Irregular menses | 28% | 35% | 0.34 |
Severe pain | 42% | 77% | 0.001 |
Dysmenorrhea | 42% | 96% | 0.0001 |
Dyspareunia | 28% | 69% | 0.001 |
Subjects with the non-variant KRAS allele had severe pelvic pain, dyspareunia and dysmenorrhea more frequently than patients with the alternative KRAS allele. Subjects with the variant KRAS allele were more likely to be infertile. Mean age and severity were not different. n = 41 subjects with KRAS variant and 91 subjects with the WT allele.